The Comparative Evaluation of the Therapeutic Effects of Autologous Cytokine-Rich Serum and Platelet-Rich Plasma in an Experimental Endometriosis Model
Autologous cytokine-rich serum (ACRS) and platelet-rich plasma (PRP) both reduced endometriotic lesion scores, with ACRS showing superior anti-inflammatory effects but higher angiogenesis and fibrosis markers compared to PRP.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
This preprint compares Autologous Cytokine-Rich Serum (ACRS) and Platelet-Rich Plasma (PRP) as autologous intraabdominal treatments in a surgically induced rat model of endometriosis, evaluating inflammation, angiogenesis, and myofibroblast activity. Thirty-six adult female Wistar Albino rats were assigned to groups receiving endometriosis plus either ACRS or PRP (or distilled water), and lesion tissues were excised for histopathological scoring and immunohistochemistry for TNF-α, IL-6, VEGFA, and α-SMA. Both ACRS and PRP significantly reduced histopathological scores versus the endometriosis-only group; ACRS produced greater reductions in TNF-α and IL-6, while also showing higher VEGFA and α-SMA expression than PRP, suggesting relatively stronger angiogenic and fibrotic responses. A major caveat is that this is an unreviewed preprint, and findings come from an experimental rat model rather than human outcomes. This paper is centrally about endometriosis — it tests ACRS versus PRP in an experimental endometriosis model and reports molecular and histopathological effects.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (3)
References (19)
- Central changes associated with chronic pelvic pain and endometriosis via openalex
- Endometriosis via openalex
- Implantation failure: molecular mechanisms and clinical treatment via openalex
- W2014709498 via openalex
- W2064413596 via openalex
- W2087122544 via openalex
- W2097763985 via openalex
- W2099204150 via openalex
- W2140246703 via openalex
- W2159228424 via openalex
- W2886868613 via openalex
- W4211081176 via openalex
- W4385755525 via openalex
- W4400478058 via openalex
- W6654678134 via openalex
- W193410492 via openalex
- W6705108472 via openalex
- W1971586374 via openalex
- W1982466133 via openalex
Source provenance
- europepmc
- last seen: 2026-06-15T06:13:43.845377+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00